ESC 365 - Inhibition of TASK-1 by gene therapy and pharmacological compounds suppresses atrial fibrillation in a large animal model

ESC Premium Access

Inhibition of TASK-1 by gene therapy and pharmacological compounds suppresses atrial fibrillation in a large animal model

Session: New approaches to the treatment of atrial fibrillation

Topic: Ion Channels, Electrophysiology

Speaker: Professor C. Schmidt (Heidelberg, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Constanze Schmidt

University Hospital Heidelberg, Heidelberg (Germany)

5 presentations

0 follower

4 more presentations in this session

New approaches to the treatment of atrial fibrillation - State of the art

Speaker: Professor D. Dobrev (Essen, DE)

Titin-truncating variants associates with atrial fibrillation, compromises assembly of the sarcomere

Speaker: Doctor M. Olesen (Copenhagen, DK)

Local optogenetic therapy for acute shock-free termination of atrial fibrillation in vivo

Speaker: Doctor E. Nyns (Leiden, NL)

Translational challenges in atrial fibrillation

Speaker: Doctor H. Spronk (Maastrich, NL)

Access the full session

New approaches to the treatment of atrial fibrillation

Speakers: Professor C. Schmidt, Professor D. Dobrev, Doctor M. Olesen, Doctor E. Nyns, Doctor H. Spronk

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources